Newsbenzinga
Ionis Climbs As FDA Clears New Therapy To Lower Triglycerides, Pancreatitis Risk
· Published
Article summary
Ionis wins FDA approval for Tryngolza in severe hypertriglyceridemia and signs a Recordati licensing deal for zilganersen
An excerpt from the original article.
Comments —
Loading comments…